The funding type Implementation Projects aims to facilitate and fund practical implementation of specific innovations / new methods in the field of oncology that have already been positively evaluated in scientific research (with demonstrable evidence on effectiveness/added value compared to current practice in terms of better care outcomes, (cost)efficiency, effectivity, and safety). The aim of implementation projects is to make the innovation/new method accessible to the target group (patient/public/care provider) at a national level, so that everyone within the target group will receive the same healthcare.
The aim of implementation projects is to make the innovation/new method accessible to the target group (patient/public/care provider) at a national level, so that everyone within the target group will receive the same healthcare. Implementation Projects are aimed at ensuring that the specific innovations / new methods get a structural place in the daily practice of relevant stakeholders, resulting in a pre-defined measurable improvement. This funding type contributes to the realisation of less cancer, more cure or a better quality of life for cancer patients, both current and former. Potential applicants include not only researchers but also individuals who are able to generate public support in practice, such as implementation experts, quality officers, (research)nurses, medical specialists, or primary care providers. The project leader is not required to hold a PhD.
The term specific innovation / new method refers to any intervention, diagnostic tool, technique, application, innovation, new method or change in care and / or daily routine of caregivers, patients or other end users. The aim is always to make improvements in healthcare, in terms of better care outcomes, (cost)efficiency, effectivity, and safety.
Applying is possible for projects led by a Dutch-based project team. The project needs to aim to achieve specific milestones and endpoints. To this end, a clear description of the intended specific innovation/new method, how it will be implemented, how it is expected to work, and process evaluation must be part of the project plan. It is needed in advance to define when the implementation project is considered successful. Therefore, predefined endpoints and outcomes need to be formulated. Outcome measures may be intermediate or at process level and do not always have to be at patient (or other end user) level.
Projects that satisfy all of the following criteria or characteristics will be considered.
Implementation of a specific innovation / new method:
- for which sufficient evidence is available upon which (national) implementation is justified or the project plan must contain a plan how to bridge a specific identified ‘evidence gap’ in the available evidence in order to justify parallel or subsequent (national) implementation. By ‘sufficient evidence upon which (national) implementation is justified’ is meant that the specific innovation/ new method has been sufficiently developed, has been evaluated positively in a clinical/ real world setting, with demonstrable added value compared to the current practice in terms of quality improvement, effectiveness, and ideally also in cost-effectiveness/efficiency, and the safety of the innovation/method has been established;
- which can be expected to make a substantial contribution (directly upon implementation or otherwise within five years after completion of the implementation process) to the KWF’s mission objectives: less cancer, more cures and a better quality of life;
- on a regional and eventually national scale: the final optimisation of a specific innovation / new method that includes scaling up from local to regional and eventually to national use can be a part of the Implementation Project.
Consideration is also given to Implementation Projects (that satisfy the criteria above, and):
- that include a foreign component, provided that the project’s main focus lies in the Netherlands and that it will be implemented in the Netherlands;
- that include analysis of the barriers and facilitators to the implementation or testing the chosen implementation strategy on effectiveness for the specific innovation/new method. It is strongly encouraged to include such an analysis as part of the Implementation Project. However, please note, the central focus of the application must be the (practical) implementation of the specific innovation/ new method and not general implementation research beforehand.
Projects with any of the following characteristics will not be considered:
- Basic, translational research and clinical research, applications still under development, impact studies and validation research (including phase III clinical studies); these are not Implementation Projects but preparatory research activities (please note: these can be submitted within another funding type within the Programme Research and Implementation, PO&I);
- Real-world research not aimed at (national) implementation of a specific innovation / new method;
- Projects or activities for individual, local optimisation, without the intent to scale up to regional and/or national implementation of the specific innovation /new method;
- Projects or activities involving already existing innovations/methods that do not involve direct implementation activities of specific innovations / new methods (e.g. the centralisation of healthcare);
- General awareness campaigns (e.g. regarding risk factors);
- Marketing activities undertaken by private parties;
- Generic implementation issues (within certain areas of concern in the fight against cancer), generic knowledge sharing and advocacy for the benefit of implementation;
- Dissemination of knowledge focused on the further development of the specific innovation / new method;
- Implementation projects commissioned by for-profit organisations. (Collaboration with for-profit organisations is permitted, however, as long as it is clearly specified in the project proposal);
- Implementation research in which the major focus is on research and not on implementation (i.e. general implementation research. Please note: this can be submitted within another funding type within the Programme Research and Implementation, PO&I).
The project team
The implementation project team should comprise of the best possible team, containing all relevant expertise. This team would minimally be made up of key players such as
- the project leader, who is the driving force, and who is able to generate public support in practice (i.e., a quality officer, implementation expert, (research)nurse, a medical specialist, or primary care provider etc.). Please note: The project leader is not required to hold a PhD;
- clinician and/or researcher who was involved in the development of the (to be implemented) innovation / method, and who is recognised as an authority in the field;
- Implementation expert (within the Dutch healthcare sector);
Ideally also other specialists with relevant expertise are also part of the team (depending on the kind of implementation project), such as:
- HTA/MTA- expert
- communication specialist
- marketing specialist
- technical expert
Applications that come under the remit of any of our other funding types (i.e. research focussed applications) will not be supported. When this is the case, the application will not be processed and it has to be submitted within the relevant track in the next coming call.